Abstract:Background Cause-specific prevalence data of vision loss and blindness is fundamental for making public health policies and is essential for prioritizing scientific advances and industry research. Methods Cause-specific vision loss data from the Global Health Data Exchange was used. The burden of vision loss was measured by prevalence and years lived with disability (YLDs). Findings In 2019, uncorrected refractory error and cataract were the most common causes for vision loss and blindness globally. Women have higher rates of cataract, age-related macular degeneration (AMD), and diabetic retinopathy (DR) than men. In the past 30 years, the prevalence of moderate/severe vision loss and blindness due to neonatal disorders has increased by 13.73 and 33.53%, respectively. Retinopathy of prematurity (ROP) is the major cause of neonatal disorders related vision loss. In 2019, ROP caused 101.6 thousand [95% uncertainty intervals (UI) 77.5–128.2] cases of vision impairment, including 49.1 thousand (95% UI 28.1–75.1) moderate vision loss, 27.5 thousand (95% UI 19.3–36.60) severe vision loss and, 25.0 thousand (95% UI 14.6–35.8) blindness. The prevalence of new-onset ROP in Africa and East Asia was significantly higher than other regions. Variation of preterm birth prevalence can explain 49.8% geometry variation of ROP-related vision loss burden among 204 countries and territories. After adjusting for preterm prevalence, government health spending per total health spending (%), rather than total health spending per person, was associated with a reduced burden of ROP-related vision loss in 2019 (−0.19 YLDs for 10% increment). By 2050, prevalence of moderate, severe vision loss and blindness due to ROP is expected to reach 43.6 (95% UI 35.1–52.0), 23.2 (95% UI 19.4–27.1), 31.9 (95% UI 29.7–34.1) per 100,000 population. Conclusion The global burden of vision loss and blindness highlights the prevalent of ROP, a major and avoidable cause for childhood vision loss. Advanced screening techniques and treatments have shown to be effective in preventing ROP-related vision loss and are urgently needed in regions with high ROP-related blindness rates, including Africa and East Asia.

Prevention and treatment of avoidable blindness in infants and young children

[Be Cautious to Treat Retinopathy of Prematurity with Anti-Vascular Endothelial Growth Factor Pharmacotherapy].

Emphasizing the Prevention and Treatment for Retinopathy of Prematurity

Prevalence, Years Lived With Disability, and Time Trends for 16 Causes of Blindness and Vision Impairment: Findings Highlight Retinopathy of Prematurity

Childhood vision impairment and blindness in West Africa: public health measures and implications for systemic health

A Survey of Blindness and Low Vision in Students in a School for the Blind in Shanghai, China

Managing the apparently blind child presenting in the first year of life: A review

Current management of infantile cataracts

A research on healthy quality of population and on the prevention and cure of blindness

Prevalence and causes of childhood blindness in Huidong County, South China, primary ascertained by the key informants

Review of treatments for retinopathy of the premature in Africa

Screening, Genetics, Risk Factors, and Treatment of Neonatal Cataracts

Retinopathy of Prematurity: A Global Perspective and Recent Developments.

The Prevalence of Cataract in Children

Focus of glaucoma prevention and control in China at present

Spectacle-wearing compliance and its associated determinants among infants with bilateral corrective refractive errors: An observational study

Corneal blindness in the developing world: The role of prevention strategies

Cerebral injury and retinopathy as risk factors for blindness in extremely preterm infants

Pediatric Cataract: Disparately Blinding Globally and in the United States

Preserving sight: Managing and preventing diabetic retinopathy

The effects of preterm birth on visual development